Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Licensing opportunity announced: liposomal compound for treatment of ARDS

Jan. 19, 1999

New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein

Jan. 19, 1999

Research at Jouveinal leads to potent and selective PDE4 inhibitors

Jan. 18, 1999

Teijin in-licenses novel asthma therapeutic from Byk Gulden

Jan. 18, 1999

Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma

Jan. 15, 1999

Seretide cleared for marketing in most E.U. countries

Jan. 15, 1999

Novel condensed pyridazines claimed by Takeda for allergic conditions

Jan. 13, 1999

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Jan. 11, 1999

Magainin and Genentech enter collaboration for asthma treatment

Jan. 11, 1999

New LTB4 receptor antagonists disclosed by Boehringer Ingelheim

Dec. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...